Mechanisms of Immune Evasion in PTEN Loss Prostate Cancer
<i>PTEN</i> (phosphatase and tensin homolog) is a frequently lost tumor suppressor gene in prostate cancer, leading to aggressive tumor behavior and poor clinical outcomes. <i>PTEN</i> loss results in aberrant activation of the PI3K/AKT/mTOR pathway, promoting oncogenesis. Th...
Saved in:
| Main Authors: | Jorge Esteban-Villarrubia, Pablo Alvarez Ballesteros, Miguel Martín-Serrano, María Ruiz Vico, Juan M Funes, Guillermo de Velasco, Elena Castro, David Olmos, Daniel Castellano, Enrique González-Billalabeitia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Immuno |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-5601/4/4/28 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current advances on the role of ferroptosis in tumor immune evasion
by: Changlin Gao, et al.
Published: (2024-12-01) -
Overcoming immune evasion with innovative multi-target approaches for glioblastoma
by: Hai Su, et al.
Published: (2025-01-01) -
Evaluation of social deprivation as a modifier of phenotypic divergence in PTEN Hamartoma Tumor Syndrome
by: Parker L. Bussies, et al.
Published: (2025-01-01) -
Immunome profiling in prostate cancer: a guide for clinicians
by: Luis San-Jose Manso, et al.
Published: (2024-11-01) -
YTHDF1 gene inhibits epilepsy progression by epigenetic activation of PTEN gene
by: Mingxia Li, et al.
Published: (2024-10-01)